重度の血友性Aの患者における因子VIII遺伝子の再編成
A C Goodeve1, F E Preston, I R Peake
1Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield, UK.
Lancet (London, England)
|February 5, 1994
まとめ
Intron 22 遺伝子の因子VIIIの再編成は,多くの家族で重度の血友病Aを引き起こす. これらの遺伝的変化を検出することは,血友病患者の阻害剤発達の予測に役立ちます.
科学分野:
- 遺伝学 遺伝学とは
- 血液学 ヘマトロジ
- 分子生物学は分子生物学である.
背景:
- Intron 22の因子VIII (FVIII) 遺伝子の再編成は,重度の血友病Aの重要な原因であり,患者の約50%に影響を与える.
- これらの再編成は,X染色体の長腕の先端の内染色体交換を伴うもので,その中断点はFVIIIイントロン22の内にある.
研究 の 目的:
- 重度のA型血友病の家族におけるFVIII遺伝子イントロン22の再編成の有病率を調査する.
- これらの再配列の存在とFVIII.への阻害剤の発達との相関性を評価する.
主な方法:
- サザンブラット分析は,FVIII遺伝子イントロン22の再編成を検出するために使用されました.
- この研究では,22人の罹患者を含む,重度の血友病Aを有する23人の無縁の家族を分析した.
主要な成果:
- FVIII遺伝子イントロン22の再編成は,関係のない23のファミリーのうち11のファミリーで確認されました.
- 遺伝子再編成を受けた10人の患者のうち,FVIII阻害剤を発症した患者は一人もいなかったが,遺伝子再編成を欠いた12人の患者のうち7人がFVIII阻害剤を発症した.
結論:
- FVIII遺伝子イントロン22の再編成のサザンブラット検出は,重度の血友病Aの貴重な診断ツールです.
- イントロン22の再編成患者のFVIII阻害剤の欠如は,潜在的な保護効果または異なる疾患メカニズムを示唆しています.
関連する概念動画
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...